Ceftriaxon 1 g intraveneus Sandoz, poeder en oplosmiddel voor oplossing voor injectie/infusie

Страна: Нидерландия

Език: нидерландски

Източник: CBG-MEB (College ter Beoordeling van Geneesmiddelen)

Активна съставка:

CEFTRIAXON DINATRIUM 3,5-WATER SAMENSTELLING overeenkomend met ; CEFTRIAXON 0-WATER

Предлага се от:

Sandoz B.V.

АТС код:

J01DD04

INN (Международно Name):

CEFTRIAXONE DISODIUM 3,5-WATER COMPOSITION corresponding to ; CEFTRIAXONE 0-WATER

Лекарствена форма:

Poeder en oplosmiddel voor oplossing voor infusie, Poeder en oplosmiddel voor oplossing voor injectie

Композиция:

WATER VOOR INJECTIE,

Начин на приложение:

Intraveneus gebruik

Терапевтична област:

Ceftriaxone

Каталог на резюме:

Hulpstoffen: WATER VOOR INJECTIE;

Дата Оторизация:

2010-10-25

Листовка

Sandoz B.V.
Page 1/7
Ceftriaxon Sandoz
RVG 104048-56-57-60-61
1312-V5
1.3.1.2 Labelling
Juli 2019
LABELLING
PARTICULARS TO APPEAR ON THE OUTER PACKAGING
CARTON
1.
NAME OF THE MEDICINAL PRODUCT
Ceftriaxon 0,25 g intramusculair Sandoz, poeder en oplosmiddel voor
oplossing voor injectie
Ceftriaxon 0,5 g intramusculair Sandoz, poeder en oplosmiddel voor
oplossing voor injectie
Ceftriaxon 1 g intramusculair Sandoz, poeder en oplosmiddel voor
oplossing voor injectie
Ceftriaxon 1 g intraveneus Sandoz, poeder en oplosmiddel voor
oplossing voor injectie/infusie
ceftriaxon
2.
STATEMENT OF ACTIVE SUBSTANCE(S)
[Nationally completed name] 0.25 g powder and solvent for solution for
i.m. injection:
Each vial contains: 0.25 g ceftriaxone (as ceftriaxone disodium,
hydrated)
Each ampoule contains: 1% (20 mg/2 ml) lidocaine hydrochloride
solution as a solvent
[Nationally completed name] 0.5 g powder and solvent for solution for
i.m. injection:
Each vial contains: 0.5 g ceftriaxone (as ceftriaxone disodium,
hydrated)
Each ampoule contains: 1% (20 mg/2 ml) lidocaine hydrochloride
solution as a solvent
[Nationally completed name] 1 g powder and solvent for solution for
i.m. injection:
Each vial contains: 1 g ceftriaxone (as ceftriaxone disodium,
hydrated)
Each ampoule contains: 1% (35 mg/3.5 ml) lidocaine hydrochloride
solution as a solvent
[Nationally completed name] 1 g powder and solvent for solution for
i.v. injection/infusion:
Each vial contains: 1 g ceftriaxone (as ceftriaxone disodium,
hydrated)
Each ampoule contains: 10 ml water for injection as a solvent
3.
LIST OF EXCIPIENTS
_[Nationally completed name] 0.25 g powder and solvent for solution
for injection: _
Contains lidocaine hydrochloride, water for injections, sodium
hydrogen carbonate.
_[Nationally completed name] 0.5 g, 1 g powder and solvent for
solution for injection: _
Contains lidocaine hydrochloride, water for injections, sodium
hydrogen carbonate, sodium.
_[Nationally completed name] 1 g powder and solvent for solution for
injection/infusion: _
Contains water for

Данни за продукта

Sandoz B.V.
Page 1/24
Ceftriaxon Sandoz
RVG 104048-56-57-60-61
1311-V9
1.3.1.1 Summary of Product Characteristics
Juli 2019
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT
Ceftriaxon 0,25 g intramusculair Sandoz, poeder en oplosmiddel voor
oplossing voor injectie
Ceftriaxon 0,5 g intramusculair Sandoz, poeder en oplosmiddel voor
oplossing voor injectie
Ceftriaxon 1 g intramusculair Sandoz, poeder en oplosmiddel voor
oplossing voor injectie
Ceftriaxon 1 g intraveneus Sandoz, poeder en oplosmiddel voor
oplossing voor injectie/infusie
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
[Nationally completed name] 0.25 g powder and solvent for solution for
i.m. injection:
Each vial contains: 0.25 g ceftriaxone (as ceftriaxone disodium,
hydrated)
Each ampoule contains: 1% (20 mg/2 ml) lidocaine hydrochloride
solution as a solvent
[Nationally completed name] 0.5 g powder and solvent for solution for
i.m. injection:
Each vial contains: 0.5 g ceftriaxone (as ceftriaxone disodium,
hydrated)
Each ampoule contains: 1% (20 mg/2 ml) lidocaine hydrochloride
solution as a solvent
[Nationally completed name] 1 g powder and solvent for solution for
i.m. injection:
Each vial contains: 1 g ceftriaxone (as ceftriaxone disodium,
hydrated)
Each ampoule contains: 1% (35 mg/3.5 ml) lidocaine hydrochloride
solution as a solvent
[Nationally completed name] 1 g powder and solvent for solution for
i.v. injection/infusion:
Each vial contains: 1 g ceftriaxone (as ceftriaxone disodium,
hydrated)
Each ampoule contains: 10 ml water for injection as a solvent
Excipients with known effect:
Each vial of ceftriaxone 0.5 g contains 1.8 mmol sodium (42 mg
sodium).
Each vial of ceftriaxone 1 g contains 3.6 mmol sodium (83 mg sodium).
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Powder and solvent for solution for injection/infusion.
The powder is coloured white to yellowish.
The solvent is a clear and colourless solution.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Sandoz B.V.
Page 2/24
Ceftriaxon Sandoz